On November 9th, 2023, the Board of Trustees of the International Vaccine Institute (IVI) visited the ST Pharm Banwol Campus.

ST Pharm introduced ST Pharm's own mRNA technology platforms, SmartCap® and STLNP®, and presented the 'Expedite-100 Days Project,' a strategy for mRNA vaccine development against emerging infectious disease within 100 days.

ST Pharm and IVI are committed to a strong partnership, working together to advance vaccine research against infectious diseases and are looking forward to continued collaboration, exploring new opportunities for innovation in vaccine development.